Profits fall for pharmaceutical company CSL to $US1.62 billion

  • 📰 SkyNewsAust
  • ⏱ Reading Time:
  • 6 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 6%
  • Publisher: 78%

Belgique Nouvelles Nouvelles

Belgique Dernières Nouvelles,Belgique Actualités

Blood products and pharmaceuticals company CSL saw their profit for the first half year fall eight per cent to $US1.62 billion as the result of one-off costs associated with its $16 billion takeover of Swiss company Vifor Pharma.

It’s also the final result from Chief Executive Paul Perreault – who has headed the

company for almost 10 years, where CSL shares have increased more than three-and-a-half times.

 

Merci pour votre commentaire. Votre commentaire sera publié après examen.

How the hell can this mob lose money 💵 with what they charge for a blood transfusion 😱

Sir in my family there are 7 members mother, father old age with their medicine it is impossible to run the family. I owe a lot of money and now I am bankrupt. Please give me a work visa so that I and my family can live.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

 /  🏆 7. in BE

Belgique Dernières Nouvelles, Belgique Actualités